This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.
Transfusion medicine reviews · 2010
Latest funding
- $459,000
Precision Decisions in MIS-C: Towards improving outcomes in children with COVID-19
CIHR · 2022 · Principal investigator
Post COVID hyperinflammation: A syndrome beyond the name
CIHR · 2021 · Principal investigator
1 publications.
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.
Shehata N, Palda V, Bowen T, Haddad E, Issekutz TB, Mazer B, Schellenberg R, Warrington R, Easton D, Anderson D, Hume H
Precision Decisions in MIS-C: Towards improving outcomes in children with COVID-19
Principal investigators: Yeung, Rae S; Benseler, Susanne; Haddad, Elie
Keywords: Biomarkers; Covid-19; Cytokine Storm Syndrome; Inflammation; Kawasaki Disease; Machine Learning; Management Pathways; Mis-C; Predictive Tool; Treatment
Post COVID hyperinflammation: A syndrome beyond the name
Principal investigators: Yeung, Rae S; Benseler, Susanne; Haddad, Elie
Keywords: Biomarkers; Cytokine Storm Syndrome; Kawasaki Disease; Machine Learning; Mis-C And Mis-A; Phenotype; Post Covid Hyperinflammation; Predictive Tool; Sars-Cov-2 Variants; Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.